Healthtech Investors & VC Firms in United States
2067 firms in this list, with a median first check of $500K. 520 of them lead rounds. Generated from verified public data and updated continuously.
Good Friends
San FranciscoPre-Seed–Seed$250K – $1M
5 people
Noro-Moseley Partners
AtlantaSeries A–Late Stage$5M – $20M
13 people
Protagonist
Bay Harbor IslandsPre-Seed–Series A$10K – $1M
9 people
FUSE
BellevuePre-Seed–Series A$1M – $10M
17 people
Define Ventures
San FranciscoPre-Seed–Series C$750K – $6M
27 people
K2 HealthVentures
BostonSeries A–Late Stage$10M – $100M
27 people
TMV
New YorkPre-Seed–Series A$1.5M
14 people
Rising Tide
PacificaPre-Seed–Series B
19 people
Webb Investment Network
San FranciscoPre-Seed–Series B$500K – $750K
13 people
Frist Cressey Ventures
NashvilleSeed–Series B$500K – $20M
21 people
Agent Capital
WalthamPre-Seed–Late Stage
26 people
Kicker Ventures
Menlo ParkPre-Seed–Series A$100K – $1M
29 people
StartUp Health
New YorkSeed
38 people
Tau Ventures
Palo AltoPre-Seed–Late Stage$500K
8 people
Geodesic Capital
Foster CitySeed–Late Stage
16 people
Bill & Melinda Gates Foundation
SeattlePre-Seed–Growth
33 people
Dreamers VC
El SegundoSeed–Series B$500K – $5M
9 people
Peterson Ventures
Salt Lake CitySeed$250K – $2.5M
14 people
iSelect Fund
St. LouisSeed–Late Stage$250K – $2M
10 people
Merit Capital Partners
ChicagoGrowth$20M
22 people
NaviMed Capital
RosslynGrowth$5M – $30M
30 people
SEAF
WashingtonGrowth$3M – $7M
33 people
JDRF T1D Fund
BostonSeed–Late Stage
30 people
MassMutual Ventures
SpringfieldSeed–Growth$500K – $5M
6 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.









































































































